相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Analysis of Flagellin Specific Adaptive Immnunity Reveals Links to Dysbioss in Patients With Inflammatory Bowel Disease
Laura Cook et al.
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY (2020)
Therapeutic peptides: Historical perspectives, current development trends, and future directions
Jolene L. Lau et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2018)
Effector T Helper Cell Subsets in Inflammatory Bowel Diseases
Tanbeena Imam et al.
FRONTIERS IN IMMUNOLOGY (2018)
Cancer metabolism: a therapeutic perspective
Ubaldo E. Martinez-Outschoorn et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Circulating and Tissue-Resident CD4+ T Cells With Reactivity to Intestinal Microbiota Are Abundant in Healthy Individuals and Function Is Altered During Inflammation
Ahmed N. Hegazy et al.
GASTROENTEROLOGY (2017)
Selective Induction of Homeostatic Th17 Cells in the Murine Intestine by Cholera Toxin Interacting with the Microbiota
Qing Zhao et al.
JOURNAL OF IMMUNOLOGY (2017)
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
Siew C. Ng et al.
LANCET (2017)
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study
Subra Kugathasan et al.
LANCET (2017)
Current and emerging therapeutic targets for IBD
Markus F. Neurath
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
mTOR Signaling in Growth, Metabolism, and Disease (vol 168, pg 960, 2017)
Robert A. Saxton et al.
CELL (2017)
Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans
Petra Bacher et al.
CELL (2016)
mTORC1 and mTORC2 Kinase Signaling and Glucose Metabolism Drive Follicular Helper T Cell Differentiation
Hu Zeng et al.
IMMUNITY (2016)
Emerging concepts of T cell metabolism as a target of immunotherapy
Chih-Hao Chang et al.
NATURE IMMUNOLOGY (2016)
Immunometabolism of regulatory T cells
Ryan Newton et al.
NATURE IMMUNOLOGY (2016)
mTORC1 and mTORC2 selectively regulate CD8+ T cell differentiation
Kristen N. Pollizzi et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Immune Tolerance Induction with Multiepitope Peptide Derived from Citrullinated Autoantigens Attenuates Arthritis Manifestations in Adjuvant Arthritis Rats
Smadar Gertel et al.
JOURNAL OF IMMUNOLOGY (2015)
Immunopathogenesis of IBD: current state of the art
Heitor S. P. de Souza et al.
Nature Reviews Gastroenterology & Hepatology (2015)
The use of sirolimus (rapamycin) in the management of refractory inflammatory bowel disease in children
Mohamed Mutalib et al.
JOURNAL OF CROHNS & COLITIS (2014)
Metformin-mode of action and clinical implications for diabetes and cancer
Ida Pernicova et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Tsc1 promotes the differentiation of memory CD8+ T cells via orchestrating the transcriptional and metabolic programs
Sharad Shrestha et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy
Bronwen R. Burton et al.
NATURE COMMUNICATIONS (2014)
Posttranscriptional Control of T Cell Effector Function by Aerobic Glycolysis
Chih-Hao Chang et al.
CELL (2013)
Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells
Yasuhiro Nemoto et al.
GUT (2013)
Metabolic Pathways in Immune Cell Activation and Quiescence
Erika L. Pearce et al.
IMMUNITY (2013)
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
William J. Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Regulation of Immune Responses by mTOR
Jonathan D. Powell et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 30 (2012)
AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Ken Inoki et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Metabolic switching and fuel choice during T-cell differentiation and memory development
Gerritje J. W. van der Windt et al.
IMMUNOLOGICAL REVIEWS (2012)
Acute Gastrointestinal Infection Induces Long-Lived Microbiota-Specific T Cell Responses
Timothy W. Hand et al.
SCIENCE (2012)
Host-microbiota interactions in inflammatory bowel disease
Charles O. Elson et al.
GUT MICROBES (2012)
Sirolimus Enhances the Magnitude and Quality of Viral-Specific CD8+T-Cell Responses to Vaccinia Virus Vaccination in Rhesus Macaques
A. P. Turner et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2011)
Cutting Edge: Distinct Glycolytic and Lipid Oxidative Metabolic Programs Are Essential for Effector and Regulatory CD4+ T Cell Subsets
Ryan D. Michalek et al.
JOURNAL OF IMMUNOLOGY (2011)
Genetics and pathogenesis of inflammatory bowel disease
Bernard Khor et al.
NATURE (2011)
The role of mTOR in memory CD8+T-cell differentiation
Koichi Araki et al.
IMMUNOLOGICAL REVIEWS (2010)
Inflammation Anergy in Human Intestinal Macrophages Is Due to Smad-induced IκBα Expression and NF-κB Inactivation
Lesley E. Smythies et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Microbiota innate stimulation is a prerequisite for T cell spontaneous proliferation and induction of experimental colitis
Ting Feng et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Persistent Retention of Colitogenic CD4+ Memory T Cells Causes Inflammatory Bowel Diseases to Become Intractable
Takanori Kanai et al.
INFLAMMATORY BOWEL DISEASES (2009)
Peptide immunotherapy in allergic asthma generates IL-10-dependent immunological tolerance associated with linked epitope suppression
John D. Campbell et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
mTOR regulates memory CD8 T-cell differentiation
Koichi Araki et al.
NATURE (2009)
A dominant, coordinated T regulatory cell-IgA response to the intestinal microbiota
Yingzi Cong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Use of sirolimus (rapamycin) to treat refractory Crohn's disease
D. C. O. Massey et al.
GUT (2008)
Systemic, but not intestinal, IL-7 is essential for the persistence of chronic colitis
Takayuki Tomita et al.
JOURNAL OF IMMUNOLOGY (2008)
Isolation of flagellated bacteria implicated in Crohn's disease
L. Wayne Duck et al.
INFLAMMATORY BOWEL DISEASES (2007)
Naive CD4+ T cell frequency varies for different epitopes and predicts repertoire diversity and response magnitude
James J. Moon et al.
IMMUNITY (2007)
Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations
Konstantinos A. Papadakis et al.
INFLAMMATORY BOWEL DISEASES (2007)
Bone marrow retaining colitogenic CD4(+) T cells may be a pathogenic reservoir for chronic colitis
Yasuhiro Nemoto et al.
GASTROENTEROLOGY (2007)
Rapamycin-mediated enrichment of T cells with regulatory activity in stimulated CD4+ T cell cultures is not due to the selective expansion of naturally occurring regulatory T cells but to the induction of regulatory functions in conventional CD4+ T cells
Danila Valmori et al.
JOURNAL OF IMMUNOLOGY (2006)
Natalizumab induction and maintenance therapy for Crohn's disease
WJ Sandborn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Direct access to CD4+ T cells specific for defined antigens according to CD154 expression
M Frentsch et al.
NATURE MEDICINE (2005)
Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells
M Battaglia et al.
BLOOD (2005)
Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease
SR Targan et al.
GASTROENTEROLOGY (2005)
Human intestinal macrophages display profound inflammatory anergy despite avid phagocytic and bacteriocidal activity
LE Smythies et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Bacterial flagellin is a dominant antigen in Crohn disease
MJ Lodes et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
DO11.10 and OT-II T cells recognize a C-terminal ovalbumin 323-339 epitope
JM Robertson et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
